|
|
|
Volumn 19, Issue 22, 2005, Pages
|
|
Chronic obstructive pulmonary disease and the NICE guideline.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BRONCHODILATING AGENT;
THEOPHYLLINE;
BLOOD;
CASE REPORT;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COST OF ILLNESS;
DIFFERENTIAL DIAGNOSIS;
DRUG INTERACTION;
DRUG MONITORING;
EVIDENCE BASED MEDICINE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
KINESIOTHERAPY;
MIDDLE AGED;
PEAK EXPIRATORY FLOW;
PRACTICE GUIDELINE;
PREVALENCE;
REVIEW;
RISK FACTOR;
SMOKING CESSATION;
SPIROMETRY;
UNITED KINGDOM;
VITAL CAPACITY;
ANTI-INFLAMMATORY AGENTS;
BRONCHODILATOR AGENTS;
COST OF ILLNESS;
DIAGNOSIS, DIFFERENTIAL;
DRUG INTERACTIONS;
DRUG MONITORING;
EVIDENCE-BASED MEDICINE;
EXERCISE THERAPY;
FEMALE;
FORCED EXPIRATORY VOLUME;
GREAT BRITAIN;
HUMANS;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
PRACTICE GUIDELINES;
PREVALENCE;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RISK FACTORS;
SMOKING CESSATION;
SPIROMETRY;
THEOPHYLLINE;
VITAL CAPACITY;
|
|
EID: 16244372382
PISSN: 00296570
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (41)
|
